Loading…

Alterations in coagulatory and fibrinolytic systems following an ultra-marathon

Purpose The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent. Methods We e...

Full description

Saved in:
Bibliographic Details
Published in:European journal of applied physiology 2013-11, Vol.113 (11), p.2705-2712
Main Authors: Kupchak, Brian R., Volk, Brittanie M., Kunces, Laura J., Kraemer, William J., Hoffman, Martin D., Phinney, Stephen D., Volek, Jeff S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3
cites cdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3
container_end_page 2712
container_issue 11
container_start_page 2705
container_title European journal of applied physiology
container_volume 113
creator Kupchak, Brian R.
Volk, Brittanie M.
Kunces, Laura J.
Kraemer, William J.
Hoffman, Martin D.
Phinney, Stephen D.
Volek, Jeff S.
description Purpose The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent. Methods We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and d -Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations. Results Significant ( P  ≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and d -Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and d -Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points. Conclusion The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes.
doi_str_mv 10.1007/s00421-013-2709-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1622605978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1622605978</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</originalsourceid><addsrcrecordid>eNqFkctKAzEUhoMoXqoP4EYG3LgZPblMklmW4g0K3eg6pJNMHUmTmswg8_amVEUEcZUD-f7_kHwInWO4xgDiJgEwgkvAtCQC6rLaQ8eY0brklIj97xnXR-gkpVcAkATLQ3REaC2YZPIYLaaut1H3XfCp6HzRBL0anO5DHAvtTdF2y9j54Ma-a4o0pt6uU9EG58J751cZKQbXR12udS55Cf4UHbTaJXv2eU7Q893t0-yhnC_uH2fTedkwqPpStoJyzJkGs5SVYI2oaikkt0JLWxmQQEzLbNNqoluJqRFG56ChYIimoqETdLXr3cTwNtjUq3WXGuuc9jYMSWFOCIeqFvJ_lDHKCMekyujlL_Q1DNHnhyhcccprUcOWwjuqiSGlaFu1iV3-gFFhUFsxaidGZTFqK0ZtMxefzcNybc134stEBsgOSPnKr2z8sfrP1g-MdJgO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1563697905</pqid></control><display><type>article</type><title>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</title><source>Springer Nature</source><creator>Kupchak, Brian R. ; Volk, Brittanie M. ; Kunces, Laura J. ; Kraemer, William J. ; Hoffman, Martin D. ; Phinney, Stephen D. ; Volek, Jeff S.</creator><creatorcontrib>Kupchak, Brian R. ; Volk, Brittanie M. ; Kunces, Laura J. ; Kraemer, William J. ; Hoffman, Martin D. ; Phinney, Stephen D. ; Volek, Jeff S.</creatorcontrib><description>Purpose The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent. Methods We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and d -Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations. Results Significant ( P  ≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and d -Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and d -Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points. Conclusion The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes.</description><identifier>ISSN: 1439-6319</identifier><identifier>EISSN: 1439-6327</identifier><identifier>DOI: 10.1007/s00421-013-2709-5</identifier><identifier>PMID: 23974848</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Altitude ; Antigens ; Biomedical and Life Sciences ; Biomedicine ; Creatine Kinase - blood ; Female ; Fibrinolysis ; Human Physiology ; Humans ; Male ; Marathons ; Middle Aged ; Myoglobin - blood ; Occupational Medicine/Industrial Medicine ; Original Article ; Physical Endurance - physiology ; Plasminogen Inactivators - blood ; Prothrombin - analysis ; Running - physiology ; Sports Medicine ; Thrombin - analysis ; Trails ; Ultramarathon ; Women</subject><ispartof>European journal of applied physiology, 2013-11, Vol.113 (11), p.2705-2712</ispartof><rights>Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</citedby><cites>FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23974848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kupchak, Brian R.</creatorcontrib><creatorcontrib>Volk, Brittanie M.</creatorcontrib><creatorcontrib>Kunces, Laura J.</creatorcontrib><creatorcontrib>Kraemer, William J.</creatorcontrib><creatorcontrib>Hoffman, Martin D.</creatorcontrib><creatorcontrib>Phinney, Stephen D.</creatorcontrib><creatorcontrib>Volek, Jeff S.</creatorcontrib><title>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</title><title>European journal of applied physiology</title><addtitle>Eur J Appl Physiol</addtitle><addtitle>Eur J Appl Physiol</addtitle><description>Purpose The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent. Methods We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and d -Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations. Results Significant ( P  ≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and d -Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and d -Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points. Conclusion The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes.</description><subject>Adult</subject><subject>Altitude</subject><subject>Antigens</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Creatine Kinase - blood</subject><subject>Female</subject><subject>Fibrinolysis</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Marathons</subject><subject>Middle Aged</subject><subject>Myoglobin - blood</subject><subject>Occupational Medicine/Industrial Medicine</subject><subject>Original Article</subject><subject>Physical Endurance - physiology</subject><subject>Plasminogen Inactivators - blood</subject><subject>Prothrombin - analysis</subject><subject>Running - physiology</subject><subject>Sports Medicine</subject><subject>Thrombin - analysis</subject><subject>Trails</subject><subject>Ultramarathon</subject><subject>Women</subject><issn>1439-6319</issn><issn>1439-6327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkctKAzEUhoMoXqoP4EYG3LgZPblMklmW4g0K3eg6pJNMHUmTmswg8_amVEUEcZUD-f7_kHwInWO4xgDiJgEwgkvAtCQC6rLaQ8eY0brklIj97xnXR-gkpVcAkATLQ3REaC2YZPIYLaaut1H3XfCp6HzRBL0anO5DHAvtTdF2y9j54Ma-a4o0pt6uU9EG58J751cZKQbXR12udS55Cf4UHbTaJXv2eU7Q893t0-yhnC_uH2fTedkwqPpStoJyzJkGs5SVYI2oaikkt0JLWxmQQEzLbNNqoluJqRFG56ChYIimoqETdLXr3cTwNtjUq3WXGuuc9jYMSWFOCIeqFvJ_lDHKCMekyujlL_Q1DNHnhyhcccprUcOWwjuqiSGlaFu1iV3-gFFhUFsxaidGZTFqK0ZtMxefzcNybc134stEBsgOSPnKr2z8sfrP1g-MdJgO</recordid><startdate>20131101</startdate><enddate>20131101</enddate><creator>Kupchak, Brian R.</creator><creator>Volk, Brittanie M.</creator><creator>Kunces, Laura J.</creator><creator>Kraemer, William J.</creator><creator>Hoffman, Martin D.</creator><creator>Phinney, Stephen D.</creator><creator>Volek, Jeff S.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TS</scope></search><sort><creationdate>20131101</creationdate><title>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</title><author>Kupchak, Brian R. ; Volk, Brittanie M. ; Kunces, Laura J. ; Kraemer, William J. ; Hoffman, Martin D. ; Phinney, Stephen D. ; Volek, Jeff S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Altitude</topic><topic>Antigens</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Creatine Kinase - blood</topic><topic>Female</topic><topic>Fibrinolysis</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Marathons</topic><topic>Middle Aged</topic><topic>Myoglobin - blood</topic><topic>Occupational Medicine/Industrial Medicine</topic><topic>Original Article</topic><topic>Physical Endurance - physiology</topic><topic>Plasminogen Inactivators - blood</topic><topic>Prothrombin - analysis</topic><topic>Running - physiology</topic><topic>Sports Medicine</topic><topic>Thrombin - analysis</topic><topic>Trails</topic><topic>Ultramarathon</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kupchak, Brian R.</creatorcontrib><creatorcontrib>Volk, Brittanie M.</creatorcontrib><creatorcontrib>Kunces, Laura J.</creatorcontrib><creatorcontrib>Kraemer, William J.</creatorcontrib><creatorcontrib>Hoffman, Martin D.</creatorcontrib><creatorcontrib>Phinney, Stephen D.</creatorcontrib><creatorcontrib>Volek, Jeff S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Physical Education Index</collection><jtitle>European journal of applied physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kupchak, Brian R.</au><au>Volk, Brittanie M.</au><au>Kunces, Laura J.</au><au>Kraemer, William J.</au><au>Hoffman, Martin D.</au><au>Phinney, Stephen D.</au><au>Volek, Jeff S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</atitle><jtitle>European journal of applied physiology</jtitle><stitle>Eur J Appl Physiol</stitle><addtitle>Eur J Appl Physiol</addtitle><date>2013-11-01</date><risdate>2013</risdate><volume>113</volume><issue>11</issue><spage>2705</spage><epage>2712</epage><pages>2705-2712</pages><issn>1439-6319</issn><eissn>1439-6327</eissn><abstract>Purpose The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent. Methods We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and d -Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations. Results Significant ( P  ≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and d -Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and d -Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points. Conclusion The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>23974848</pmid><doi>10.1007/s00421-013-2709-5</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1439-6319
ispartof European journal of applied physiology, 2013-11, Vol.113 (11), p.2705-2712
issn 1439-6319
1439-6327
language eng
recordid cdi_proquest_miscellaneous_1622605978
source Springer Nature
subjects Adult
Altitude
Antigens
Biomedical and Life Sciences
Biomedicine
Creatine Kinase - blood
Female
Fibrinolysis
Human Physiology
Humans
Male
Marathons
Middle Aged
Myoglobin - blood
Occupational Medicine/Industrial Medicine
Original Article
Physical Endurance - physiology
Plasminogen Inactivators - blood
Prothrombin - analysis
Running - physiology
Sports Medicine
Thrombin - analysis
Trails
Ultramarathon
Women
title Alterations in coagulatory and fibrinolytic systems following an ultra-marathon
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T04%3A33%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20in%20coagulatory%20and%20fibrinolytic%20systems%20following%20an%20ultra-marathon&rft.jtitle=European%20journal%20of%20applied%20physiology&rft.au=Kupchak,%20Brian%20R.&rft.date=2013-11-01&rft.volume=113&rft.issue=11&rft.spage=2705&rft.epage=2712&rft.pages=2705-2712&rft.issn=1439-6319&rft.eissn=1439-6327&rft_id=info:doi/10.1007/s00421-013-2709-5&rft_dat=%3Cproquest_cross%3E1622605978%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1563697905&rft_id=info:pmid/23974848&rfr_iscdi=true